Yale University

Publications

Filters: Keyword is HIV Protease Inhibitors  [Clear All Filters]
2010
Gardner, Edward M., Katherine H. Hullsiek, Edward E. Telzak, Shweta Sharma, Grace Peng, William J. Burman, Rodger D. MacArthur, Margaret Chesney, Gerald Friedland, and Sharon B. Mannheimer. "Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial." AIDS (London, England) 24, no. 3 (2010): 395-403. Abstract
2008
Mannheimer, Sharon B., Nicholas Wold, Edward M. Gardner, Edward E. Telzak, Katherine Huppler Hullsiek, Margaret Chesney, Albert W. Wu, Rodger D. MacArthur, John Matts, and Gerald Friedland. "Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 46, no. 6 (2008): 941-5. Abstract
Gardner, Edward M., Shweta Sharma, Grace Peng, Katherine Huppler Hullsiek, William J. Burman, Rodger D. MacArthur, Margaret Chesney, Edward E. Telzak, Gerald Friedland, and Sharon B. Mannheimer. "Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance." AIDS (London, England) 22, no. 1 (2008): 75-82. Abstract
2007
McCance-Katz, Elinore F., David E. Moody, Gene D. Morse, Qing Ma, Robin DiFrancesco, Gerald Friedland, Patricia Pade, and Petrie M. Rainey. "Interaction between buprenorphine and atazanavir or atazanavir/ritonavir." Drug and alcohol dependence 91, no. 2-3 (2007): 269-78. Abstract
2006
Bruce, Douglas R., and Frederick L. Altice. "Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
McCance-Katz, Elinore F., David E. Moody, Patrick F. Smith, Gene D. Morse, Gerald Friedland, Patricia Pade, Jennifer Baker, Anika Alvanzo, Peter Jatlow, and Petrie M. Rainey. "Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S235-46. Abstract
2005
Friedland, Gerald, Laurie Andrews, Tanya Schreibman, Sangeeta Agarwala, Leith Daley, Michael Child, Julia Shi, Yonghua Wang, and Edward O'Mara. "Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
Friedland, Gerald H., and Sonia G. Nagy. "Report from the 12th Retrovirus Conference. Adherence." AIDS clinical care 17, no. 4 (2005): 36.
2004
McCance-Katz, Elinore F., Petrie M. Rainey, Patrick Smith, Gene Morse, Gerald Friedland, Marc Gourevitch, and Peter Jatlow. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 2 (2004): 163-80. Abstract
Ledergerber, Bruno, Jens D. Lundgren, Sarah A. Walker, Caroline Sabin, Amy Justice, Peter Reiss, Cristina Mussini, Ferdinand Wit, Antonella d'Arminio Monforte, Rainer Weber et al. "Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes." Lancet 364, no. 9428 (2004): 51-62. Abstract
2003
McCance-Katz, Elinore F., Petrie M. Rainey, Gerald Friedland, and Peter Jatlow. "The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 37, no. 4 (2003): 476-82. Abstract